Foundations

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC6-6

DiraChart Clinical Reference
Protected section 6 of 29
← Document menu
Home Care · DiraChart

1.1 Why “WNL” alone fails

DiraChart Clinical Reference

Section NavigationPart 6 of 29PreviousNext

Worked example — Endocrine on a renal patient

Consider a patient referred for renal management. The endocrine system is unremarkable today. A note that reads “Endo: WNL” offers no defense. The same finding documented defensibly:

Endocrine Mode A example

Skilled endocrine assessment performed: capillary blood glucose 96 mg/dL, within the ordered parameter of 80–180 mg/dL; no symptoms of hypo- or hyperglycemia. Insulin/oral-hypoglycemic regimen reviewed with adherence verified. Injection sites clear without lipohypertrophy; technique accurate on observation. Feet inspected: skin intact bilaterally; monofilament 10/10 sites detected per foot. RN-level assessment required to detect glycemic pattern shifts requiring provider-directed regimen adjustment, evaluate for early micro- and macrovascular complications, monitor steroid- or medication-induced hyperglycemia, and identify subtle thyroid imbalance given concurrent renal dysfunction. Continued skilled monitoring indicated.

The reasoning sentence is the difference between a defensible visit and a denial. It does not change the clinical findings — it documents the judgment a layperson cannot supply, and the glucose is stated against the ordered parameter rather than “at baseline.”

Section NavigationPart 6 of 29PreviousNext